{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:50:04Z","timestamp":1761094204679,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["HHSH250201200016C"],"award-info":[{"award-number":["HHSH250201200016C"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"publisher","award":["N00014-17-1-2388","N00014-16-1-2020)"],"award-info":[{"award-number":["N00014-17-1-2388","N00014-16-1-2020)"]}],"id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010535","name":"Actinium Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010535","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Amneal Biosciences"},{"DOI":"10.13039\/100016316","name":"Angiocrine Bioscience, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016316","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Anonymous donation to the Medical College of Wisconsin"},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016253","name":"Atara Biotherapeutics, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016253","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001738","name":"Be The Match Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016508","name":"bluebird bio, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016508","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Bristol Myers Squibb Oncology"},{"DOI":"10.13039\/100006436","name":"Celgene Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016318","name":"Cerus Corporation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016318","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100016875","name":"Chimerix, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016875","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005895","name":"Fred Hutchinson Cancer Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005895","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gamida Cell Ltd."},{"DOI":"10.13039\/100005564","name":"Gilead Sciences, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"crossref"}]},{"name":"HistoGenetics, Inc."},{"name":"Immucor"},{"name":"Incyte Corporation"},{"DOI":"10.13039\/100017183","name":"Janssen Scientific Affairs, LLC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017183","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Juno Therapeutics; Karyopharm Therapeutics, Inc."},{"name":"Kite Pharma, Inc."},{"DOI":"10.13039\/501100014841","name":"Medac, GmbH","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014841","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004628","name":"MedImmune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008980","name":"Medical College of Wisconsin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck & Co., Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mesoblast"},{"name":"MesoScale Diagnostics, Inc."},{"name":"Millennium, the Takeda Oncology Co."},{"name":"Miltenyi Biotec, Inc."},{"name":"National Marrow Donor Program;"},{"name":"Neovii Biotech NA, Inc."},{"name":"Novartis Pharmaceuticals Corporation; Otsuka Pharmaceutical Co, Ltd. \u2013 Japan"},{"DOI":"10.13039\/100006093","name":"PCORI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pfizer, Inc"},{"name":"Pharmacyclics, LLC"},{"name":"PIRCHE AG"},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010293","name":"Seattle Genetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010293","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007343","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007343","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spectrum Pharmaceuticals, Inc."},{"DOI":"10.13039\/100006058","name":"St. Baldrick's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015234","name":"Sunesis Pharmaceuticals, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015234","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Swedish Orphan Biovitrum, Inc."},{"DOI":"10.13039\/100011957","name":"Takeda Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017070","name":"Telomere Diagnostics, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017070","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.bbmt.2017.11.003","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T02:04:04Z","timestamp":1511143444000},"page":"827-831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of HLA Alleles on Outcomes of Allogeneic Transplantation for B Cell Non-Hodgkin Lymphomas: A Center for International Blood and Marrow Transplant Research Analysis"],"prefix":"10.1016","volume":"24","author":[{"given":"Basem M.","family":"William","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Haagenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Fleischhauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Verneris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharine C.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos J.","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Fernandez-Vi\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen R.","family":"Spellman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian T.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2017.11.003_bib0010","first-page":"212","article-title":"Cancer statistics, 2011","volume":"61","author":"Siegel","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0015","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/107327481201900302","article-title":"Hematopoietic cell transplantation for B-cell lymphoma: an update","volume":"19","author":"Ayala","year":"2012","journal-title":"Cancer Control"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0020","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1200\/JCO.2012.41.9416","article-title":"Rituximab maintenance therapy after autologous stem-cell transplantation in patients with relapsed CD20(+) diffuse large B-cell lymphoma: final analysis of the collaborative trial in relapsed aggressive lymphoma","volume":"30","author":"Gisselbrecht","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40266-013-0076-x","article-title":"Advances in conditioning regimens for older adults undergoing allogeneic stem cell transplantation to treat hematologic malignancies","volume":"30","author":"William","year":"2013","journal-title":"Drugs Aging"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0030","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bbmt.2013.01.024","article-title":"Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma","volume":"19","author":"Hamadani","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0035","first-page":"3164","article-title":"Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition","volume":"51","author":"Pandolfi","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0040","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1182\/blood.V98.6.1872","article-title":"Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8(+) T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay","volume":"98","author":"Kuzushima","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0045","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0140-6736(01)06275-4","article-title":"Survival after bone marrow transplantation from cytomegalovirus seropositive sibling donors","volume":"358","author":"Nachbaur","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0050","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1182\/blood-2011-09-382838","article-title":"TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas","volume":"120","author":"Weng","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0055","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1002\/cncr.26091","article-title":"Nonmyeloablative allogeneic stem cell transplantation in relapsed\/refractory chronic lymphocytic leukemia: long-term follow-up, prognostic factors, and effect of human leukocyte histocompatibility antigen subtype on outcome","volume":"117","author":"Khouri","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0060","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.bbmt.2006.07.001","article-title":"Human leukocyte antigen DR15 is associated with reduced relapse rate and improved survival after human leukocyte antigen-identical sibling hematopoietic stem cell transplantation","volume":"12","author":"Stern","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0065","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.bbmt.2012.02.011","article-title":"HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies","volume":"18","author":"Battiwalla","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0070","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1182\/blood-2010-01-266775","article-title":"Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology","volume":"115","author":"Wang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0075","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1182\/blood-2013-02-483420","article-title":"HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma","volume":"122","author":"Alcoceba","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0080","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1182\/blood.V122.21.507.507","article-title":"Specific KIR and HLA genotypes affect outcomes of single-agent anti-CD20 immunotherapy of follicular lymphoma","volume":"122","author":"Erbe","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0085","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1158\/2326-6066.CIR-13-0158","article-title":"CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells","volume":"2","author":"Du","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0090","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1182\/blood-2004-03-0803","article-title":"Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome","volume":"104","author":"Flomenberg","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0095","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donor, S","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0100","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0105","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.bbmt.2007.08.047","article-title":"A scheme for defining cause of death and its application in the T cell depletion trial","volume":"13","author":"Copelan","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0110","first-page":"2303","article-title":"Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation","volume":"92","author":"Ratanatharathorn","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0115","first-page":"2062","article-title":"Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors","volume":"96","author":"Nash","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.bmt.1703097","article-title":"Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation","volume":"28","author":"Hiraoka","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0125","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/bjh.14046","article-title":"Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation","volume":"174","author":"Fenske","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0130","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.bbmt.2015.07.028","article-title":"Reduced-intensity allografting as first transplantation approach in relapsed\/refractory grades one and two follicular lymphoma provides improved outcomes in long-term survivors","volume":"21","author":"Klyuchnikov","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0135","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1200\/JCO.1996.14.11.3036","article-title":"Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignancies","volume":"14","author":"van Besien","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2017.11.003_bib0140","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2217\/imt.15.128","article-title":"Antithymocyte globulin in allogeneic hematopoietic cell transplantation: benefits and limitations","volume":"8","author":"Nishihori","year":"2016","journal-title":"Immunotherapy"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117308170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117308170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:01:24Z","timestamp":1761058884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879117308170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1083879117308170"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.11.003","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of HLA Alleles on Outcomes of Allogeneic Transplantation for B Cell Non-Hodgkin Lymphomas: A Center for International Blood and Marrow Transplant Research Analysis","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}